VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Feasibility Trial

Phase 2

Completed

• Conditions: Cardiomyopathies; End-Stage Heart Failure

• Registration Number: NCT00490347
• Lead Sponsor: Ventracor

Brief Summary

The purpose of this trial is to determine the safety and feasibility of the VentrAssist LVAD in providing circulatory support for patients who require an LVAD as a bridge to cardiac transplantation.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-07
• Study First Submitted: 2007-06-20
• Study First Submitted QC: 2007-06-21
• Study First Posted: 2007-06-22
• Study Completion: 2007-10
• Status Verified: 2008-01
• Last Update Submitted: 2008-01-15
• Last Update Posted: 2008-01-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Survival

Secondary Outcome Measures

Name	Time	Method
Neurocognitive function
Quality of life
Functional status

Trial Locations

Locations (5)

University of Maryland Medical Center - Baltimore; 🇺🇸 Baltimore, Maryland, United States

Cleveland Clinic Foundation; 🇺🇸 Cleveland, Ohio, United States

University of Pittsburgh Medical Center; 🇺🇸 Pittsburgh, Pennsylvania, United States

New York Presbyterian Medical Center - Columbia; 🇺🇸 New York, New York, United States

University of Minnesota Medical Center - Fairview; 🇺🇸 Minneapolis, Minnesota, United States